A detailed history of Morgan Stanley transactions in Femasys Inc stock. As of the latest transaction made, Morgan Stanley holds 1,525 shares of FEMY stock, worth $1,448. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,525
Previous 1,525 -0.0%
Holding current value
$1,448
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.51 - $1.26 $0 - $1
-1 Reduced 0.07%
1,525 $0
Q1 2023

May 15, 2023

SELL
$0.85 - $1.29 $2,472 - $3,752
-2,909 Reduced 65.59%
1,526 $1,000
Q4 2022

Feb 14, 2023

BUY
$0.83 - $1.41 $891 - $1,514
1,074 Added 31.95%
4,435 $3,000
Q3 2022

Nov 14, 2022

BUY
$1.13 - $2.54 $2,029 - $4,561
1,796 Added 114.76%
3,361 $4,000
Q2 2022

Oct 27, 2022

BUY
$1.3 - $2.76 $48 - $102
37 Added 2.42%
1,565 $4,000
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.76 $48 - $102
37 Added 2.42%
1,565 $4,000
Q1 2022

Oct 27, 2022

SELL
$1.76 - $3.99 $65 - $147
-37 Reduced 2.36%
1,528 $3,000
Q1 2022

May 13, 2022

BUY
$1.76 - $3.99 $2,200 - $4,987
1,250 Added 449.64%
1,528 $3,000
Q3 2021

Nov 15, 2021

BUY
$6.52 - $8.5 $1,812 - $2,363
278 New
278 $2,000

Others Institutions Holding FEMY

About FEMASYS INC


  • Ticker FEMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 11,813,600
  • Market Cap $11.2M
  • Description
  • Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...
More about FEMY
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.